Found: 25
Select item for more details and to access through your institution.
Testing and interval estimation for two-sample survival comparisons with small sample sizes and unequal censoring.
- Published in:
- Biostatistics, 2010, v. 11, n. 4, p. 676, doi. 10.1093/biostatistics/kxq021
- By:
- Publication type:
- Article
A kernel method for incorporating information on disease progression in the analysis of survival.
- Published in:
- Biometrika, 1994, v. 81, n. 3, p. 527
- By:
- Publication type:
- Article
Compressed representation of brain genetic transcription.
- Published in:
- Human Brain Mapping, 2024, v. 45, n. 11, p. 1, doi. 10.1002/hbm.26795
- By:
- Publication type:
- Article
Generalized Rank Tests for Replicated Microarray Data.
- Published in:
- Statistical Applications in Genetics & Molecular Biology, 2005, v. 4, n. 1, p. 1, doi. 10.2202/1544-6115.1093
- By:
- Publication type:
- Article
Methodology for case-control studies with prevalent cases.
- Published in:
- Biometrika, 1987, v. 74, n. 1, p. 191
- By:
- Publication type:
- Article
Testing normality of errors in regression models.
- Published in:
- Biometrika, 1982, v. 69, n. 1, p. 233
- By:
- Publication type:
- Article
Estimating treatment effect in a proportional hazards model in randomized clinical trials with all-or-nothing compliance.
- Published in:
- Biometrics, 2016, v. 72, n. 3, p. 742, doi. 10.1111/biom.12472
- By:
- Publication type:
- Article
Estimation of Regression Parameters and the Hazard Function in Transformed Linear Survival Models.
- Published in:
- Biometrics, 2000, v. 56, n. 2, p. 571, doi. 10.1111/j.0006-341X.2000.00571.x
- By:
- Publication type:
- Article
Toronto Workshop on Late Recurrence in Estrogen Receptor–Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 4, p. N.PAG, doi. 10.1093/jncics/pkz050
- By:
- Publication type:
- Article
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 4, p. N.PAG, doi. 10.1093/jncics/pkz049
- By:
- Publication type:
- Article
E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer.
- Published in:
- NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-017-0053-3
- By:
- Publication type:
- Article
Adjuvant Therapy for Very Young Women With Breast Cancer: Need for Tailored Treatments.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2001, v. 93, n. 30, p. 44
- By:
- Publication type:
- Article
Weighted analyses for cohort sampling designs.
- Published in:
- Lifetime Data Analysis, 2009, v. 15, n. 1, p. 24, doi. 10.1007/s10985-008-9095-z
- By:
- Publication type:
- Article
Efficacy of radiotherapy for ovarian ablationThe contents of the current study are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.Presented as a poster presentation at the 22nd Annual San Antonio Breast Cancer Symposium, December X–X, 1999.: Results of a Breast Intergroup study
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 5, p. 969
- By:
- Publication type:
- Article
Analyses of cumulative incidence functions via non-parametric multiple imputation.
- Published in:
- Statistics in Medicine, 2008, v. 27, n. 27, p. 5709, doi. 10.1002/sim.3402
- By:
- Publication type:
- Article
Sensitivity analysis of progression-free survival with dependent withdrawal.
- Published in:
- Statistics in Medicine, 2008, v. 27, n. 8, p. 1180, doi. 10.1002/sim.3015
- By:
- Publication type:
- Article
Pragmatic approaches to address expansion cohort design.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 6, p. 1140, doi. 10.1002/cncr.27819
- By:
- Publication type:
- Article
Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient‐reported outcomes substudy.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 3, p. 536, doi. 10.1002/cncr.33939
- By:
- Publication type:
- Article
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2–negative breast cancer: A trajectory analysis of adverse events.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 24, p. 4546, doi. 10.1002/cncr.33992
- By:
- Publication type:
- Article
Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG‐ACRIN TAILORx trial.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 14, p. 2545, doi. 10.1002/cncr.33527
- By:
- Publication type:
- Article
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Noninferiority trials with nonadherence to the assigned randomized treatment.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 673, doi. 10.1177/1740774519868479
- By:
- Publication type:
- Article
An audit strategy for time-to-event outcomes measured with error: Application to five randomized controlled trials in oncology.
- Published in:
- Clinical Trials, 2013, v. 10, n. 5, p. 754, doi. 10.1177/1740774513493973
- By:
- Publication type:
- Article